"In order to raise chances, the number of clinical trials enter Phase II must be raised"

A position that a country takes in the new drug development field is decided based on the structure of clinical trials. While most clinical trials in the U.S. are on Phase I and Phase II, most Korean pharmaceutical companies are working on Phase I and Phase III clinical trials.

Chairman Dong-Hyun Ji at the Korea National Enterprise for Clinical Trials(KoNECT) said having more Phase I and Phase...